Uniam is a veterinarian-founded company focused on cat health and longevity. It has launched uniam Longevity Lab, described as Japan's first research institute dedicated to feline longevity, and has begun research activities under that initiative. The company says it plans to pursue research that could lead to future pharmaceutical development for cats. Uniam recently completed a ¥770 million Series A raise and said the funds will be used to accelerate hiring and support the Longevity Lab's operations. The public materials do not disclose revenue, user metrics, investor identities, or earlier funding rounds.

Total raised

$5M

Funding rounds

2

Latest round

Series A

Latest activity

Apr 2026